XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenue        
Total revenue $ 180,123 $ 156,060 $ 510,397 $ 381,867
Operating expenses        
Cost of services 121,823 131,130 402,106 315,925
General and administrative expenses 16,270 7,950 39,660 30,031
Depreciation and amortization 4,674 4,920 14,004 13,793
Provision for doubtful accounts 0 0 0 (1,363)
Impairment of intangibles 0 1,994 0 1,994
Total expenses 142,767 145,994 455,770 360,380
Income from operations 37,356 10,066 54,627 21,487
Other (expense) income        
Income from equity method investments 403 2,054 3,291 1,162
Equity Method Investment, Realized Gain (Loss) on Disposal 0 0 99,647 0
Interest expense (2,466) (828) (8,007) (1,350)
Interest income 752 509 2,544 1,305
Other income 130 2,620 1,514 2,832
Total other (expense) income, net (1,181) 4,355 98,989 3,949
Income before provision for income taxes 36,175 14,421 153,616 25,436
Provision for income taxes 10,751 3,682 44,204 6,483
Net income (loss) 25,424 10,739 109,412 18,953
Net income attributable to noncontrolling interest 8,711 7,035 81,603 11,564
Net income attributable to Apollo Medical Holdings, Inc. $ 16,713 $ 3,704 $ 27,809 $ 7,389
Earnings per share – basic (in dollars per share) $ 0.46 $ 0.11 $ 0.77 $ 0.21
Earnings per share – diluted (in dollars per share) $ 0.45 $ 0.10 $ 0.75 $ 0.20
Capitation, net        
Revenue        
Total revenue $ 135,032 $ 130,807 $ 416,402 $ 305,548
Risk pool settlements and incentives        
Revenue        
Total revenue 30,916 11,355 54,155 32,640
Management fee income        
Revenue        
Total revenue 8,707 8,518 26,212 27,867
Fee-for-service, net        
Revenue        
Total revenue 3,737 4,100 9,434 12,059
Other income        
Revenue        
Total revenue $ 1,731 $ 1,280 $ 4,194 $ 3,753